- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06818669
Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives (CVD-FIT)
Cardiovascular Risk Reduction for Adults With Food Insecurity Using Structured Incentives (CVD-FIT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Overview: 200 African American adults at risk for CVD with food insecurity will be randomized 1:1 to CVD-FIT or enhanced usual care (CVD risk reduction education). Each patient will be followed for 12 months, with study visits at baseline, 3, 6, and 12 months. The primary outcome will be 10-year CVD risk using the Pooled Cohort Equation at 12 months post-randomization while the secondary outcomes will be quality of life at 12 months post-randomization and cost-effectiveness of the CVD-FIT intervention compared to enhanced usual care.
Patient Randomization. A permuted block randomization method will be used to assign subjects to intervention or control. All subjects who are randomized will be entered into the study database and analyzed according to CONSORT guidelines.
Description of the CVD-FIT Intervention: The CVD-FIT intervention will incorporate 1) $100 monthly income supplementation; 2) $50 weekly structured incentive for the purchase of healthy food options; and 3) evidence-based telephone delivered CVD risk reduction education and skills training.
Enhanced Usual Care Control Group: Participants randomized to the enhanced usual care group will receive the same mailed education and health educator delivered education and skills training sessions as the CVD-FIT intervention group.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rebekah J Walker, PhD
- Phone Number: 716-829-5741
- Email: rbwalker@buffalo.edu
Study Contact Backup
- Name: Jocelyn Stooks, MPH
- Phone Number: 716-829-2364
- Email: jstooks@buffalo.edu
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14203
- Recruiting
- University at Buffalo
-
Contact:
- Rebekah J Walker, PhD
- Phone Number: 716-829-5741
- Email: rbwalker@buffalo.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- self-report as African American/non-Hispanic Black
- screen positive for food insecurity over the past 12-months using a food insecurity risk tool developed through completion of the research team's current NIH funded R01 (R01MD013826)
- at risk for CVD defined as age ≥40 years and having a clinical diagnosis of diabetes, or hypertension, or hyperlipidemia, or being overweight/obese (defined as a BMI>25), or being a current smoker
- able to communicate in English.
Exclusion Criteria:
- Mental confusion on interview suggesting significant dementia
- Participation in other cardiovascular disease clinical trials
- Alcohol or drug abuse/dependency based on screening using CAGE questionnaire
- Active psychosis or acute mental disorder based on self-report
- Life expectancy <12 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CVD-FIT
The structured incentive will include monthly supplemental income plus weekly reimbursement for the purchase of healthy food options.
Education for CVD risk reduction will include mailed education and telephone calls with a trained health educator.
|
The structured incentive will include monthly supplemental income plus weekly reimbursement for the purchase of healthy food options.
Education for CVD risk reduction will include mailed education and telephone calls with a trained health educator.
|
|
Active Comparator: Enhanced Usual Care
Education for CVD risk reduction will include mailed education and telephone calls with a trained health educator.
|
Education for CVD risk reduction will include mailed education and telephone calls with a trained health educator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
10-Year CVD Risk
Time Frame: baseline, 3-months, 6-months, and 12-months post randomization
|
10-year CVD risk will be measured by the Pooled Cohort risk reduction equation recommended for race- and sex- specific risk calculation for African Americans 40 to 79 years of age.
|
baseline, 3-months, 6-months, and 12-months post randomization
|
|
CVD Risk - PREVENT
Time Frame: baseline, 3-months, 6-months, and 12-months post randomization
|
CVD Risk will be measured using the PREVENT equation
|
baseline, 3-months, 6-months, and 12-months post randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical and Mental Health Related Quality of Life
Time Frame: baseline, 3-months, 6-months, and 12-months post randomization
|
Quality of Life will be measured using the SF-12 questionnaire and reported as physical health related and mental health related scores (score ranges from 0 to 100 with higher numbers indicating better quality of life)
|
baseline, 3-months, 6-months, and 12-months post randomization
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MD018721 (U.S. NIH Grant/Contract)
- 1R01MD018721-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on CVD-FIT
-
VA Office of Research and DevelopmentCompletedHypertension | Cardiovascular Disease | Diabetes | HyperlipidemiaUnited States
-
McGill UniversityPfizerCompletedHypertension | Obesity | Diabetes | Sedentary Lifestyle | Dyslipidemia | Cigarette SmokingCanada
-
Case Western Reserve UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke University; University... and other collaboratorsCompletedHypertension | HIV-1-infectionUnited States
-
Genomics PLCNHS North of England Commissioning Support (NECS)CompletedCardiovascular DiseasesUnited Kingdom
-
Debra MoserUniversity of Kentucky Center for Excellence in Rural Health-HazardCompletedDepression | Hypertension | Obesity | HyperlipidemiaUnited States
-
University of BedfordshireNot yet recruitingCardiovascular Diseases | Sedentary Behavior
-
Centro Cardiologico MonzinoUnknown
-
Whisper.aiSan Jose State UniversityRecruitingHearing LossUnited States
-
University of California, IrvineCompletedCardiovascular Diseases | Cardiovascular Risk FactorUnited States
-
UPecon Foundation, Inc.University of LausanneUnknownCardiovascular Diseases | Cardiovascular Risk FactorPhilippines